suck pdf from google scholar
unlimited free pdf from europmc19536319    free
PDF from PMC    free
html from PMC    free
PDF vom PMID19536319 :   free
PDF vom PMID19536319 :   free
suck pdf from library genesis
English Wikipedia

Nephropedia Template TP (

Twit Text


  • DeepDyve
  • Pubget Overpricing


  • lüll
  • Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
  • Ruhlmann C; Herrstedt J
  • Ther Clin Risk Manag 2009[Apr]; 5 (2): 375-84
  • Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. The knowledge of the pathogenesis and neuropharmacology of CINV has expanded enormously over the last decades, the most significant discoveries being the role of 5-hydroxytryptamine (5-HT)(3)- and neurokinin (NK)(1) receptors in the emetic reflex arch. This has led to the development of two new classes of antiemetics acting as highly selective antagonists at one of these receptors. These drugs have had a huge impact in the protection from chemotherapy-induced vomiting, whereas the effect on nausea seems to be limited. The first NK(1) receptor antagonist, aprepitant, became clinically available in 2003, and casopitant, the second in this class of antiemetics, has now completed phase III trials. This review delineates the properties and clinical use of casopitant in the prevention of CINV.
  • ä





  • *{{pmid19536319}}
    *<b>[http://www.kidney.de/mlpefetch.php?search=19536319 Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting ]</b> Ther Clin Risk Manag 2009; 5(2) ; 375-84 Ruhlmann C; Herrstedt J

        *19536319*

    Nephropedia PMID record

    Deutsche Wikipedia - im Artikel

    Hier den unten stehenden Textblock hineinkopieren

    Ther Clin Risk Manag

    375 2.5 2009